GlaxoSmithKline (India)

About

In recent decades, authors affiliated with GlaxoSmithKline (India) have published 991 papers, which have received a total of 36.1k indexed citations. Scholars at this organization have produced 225 papers in Epidemiology, 166 papers in Pulmonary and Respiratory Medicine and 138 papers in Molecular Biology on the topics of Asthma and respiratory diseases (103 papers), Pneumonia and Respiratory Infections (72 papers) and Respiratory and Cough-Related Research (63 papers). Their work is cited by papers focused on Physiology (8.8k citations), Pulmonary and Respiratory Medicine (8.7k citations) and Molecular Biology (5.5k citations). Authors at GlaxoSmithKline (India) collaborate with scholars in India, United States and United Kingdom and have published in prestigious journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet. Some of GlaxoSmithKline (India)'s most productive authors include John Hayler, A.S. Wells, Denis Prat, Steven W. Yancey, Ian Pavord, Héctor Ortega, Oliver N. Keene, Peter J. Dunn, Helen F. Sneddon and Sarah Abou‐Shehada.

In The Last Decade

GlaxoSmithKline (India)

924 papers receiving 36.0k citations

Fields of papers published by authors at GlaxoSmithKline (India)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with GlaxoSmithKline (India) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with GlaxoSmithKline (India) at the time of their publication.

Countries citing scholars working at GlaxoSmithKline (India)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at GlaxoSmithKline (India). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at GlaxoSmithKline (India) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GlaxoSmithKline (India) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2026